Dextromethorphan: A review of N-methyl-D-aspartate receptor antagonist in the management of pain

CNS Drug Reviews

Volumn 13, Issue 1, 2007, Pages 96-106

  Siu, Anita ^a   Drachtman, Richard ^b  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Analgesics; Antitussive agents; Dextromethorphan; Levorphanol; Methotrexate; N methylaspartate; NMDA antagonists; Pain

Indexed keywords

ANTITUSSIVE AGENT; CODEINE; DEXTROMETHORPHAN; DIPHENHYDRAMINE; EXCITATORY AMINO ACID; HOMOCYSTEINE; LEVORPHANOL; METHOTREXATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; OPIATE;

ANAPHYLAXIS; ATAXIA; CANCER PAIN; CANCER PATIENT; CENTRAL NERVOUS SYSTEM DEPRESSION; CONSTIPATION; COUGHING; DIARRHEA; DISTORTED VISION; DIZZINESS; DROWSINESS; DRUG BINDING SITE; DRUG ERUPTION; DRUG MEGADOSE; DRUG OVERDOSE; DRUG POTENTIATION; DRUNK SENSATION; DYSARTHRIA; DYSTONIA; FATIGUE; HEADACHE; HEMIPLEGIA; HISTAMINE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERPYREXIA; INSOMNIA; IRRITABILITY; MALAISE; MANIA; MASTOCYTOSIS; MOOD DISORDER; MYALGIA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPATHY; NEUROPROTECTION; NEUROTOXICITY; NIGHT SWEAT; NOCICEPTION; NYSTAGMUS; OPISTHOTONUS; OSTEOSARCOMA; PAIN; PSORIASIS; PSYCHOSIS; RACING THOUGHT; RECOMMENDED DRUG DOSE; RESTLESSNESS; REVIEW; RHEUMATOID ARTHRITIS; SEIZURE; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; VISUAL HALLUCINATION;

ANIMALS; CLINICAL TRIALS; DEXTROMETHORPHAN; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34247892220     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2007.00006.x     Document Type: Review

References (49)

1. Aanonsen LM, Wilcox GL (1987) Nociceptive action of excitatory amino acids in the mouse: Effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 243 : 9 19.
2. Abraham RB. Marouani N, Kollender Y, Meller I, Weinbroum A (2002) Dextromethorphan for phantom pain attenuation in cancer amputees: A double blind crossover trial involving three patients. Clin J Pain 18 : 282 285.
3. Achamallah NS (1992) Visual hallucinations after combining fluoxetine and dextromethorphan. Am J Psychiatry 149 : 1406.
4. Baselt RC (2002) Disposition of toxic drugs and chemicals in man, 6th Edition. Foster City, CA : Chemical Toxicology Institute.
5. Battaglia G, Rustioni A (1988) Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol 27 : 302 312.
6. Bem JL, Peck R (1992) Dextromethorphan. An overview of safety issues. Drug Saf 7 : 190 199.
7. Bettachi CJ, Kamen BA, Cush JJ (1999) Post-methotrexate (MTX) CNS toxicity: Symptom reduction with dextromethorphan. Arthritis Rheum 42 : S236.
8. Bostwick JM (1996) Dextromethorphan-induced manic symptoms in a bipolar patient on lithium (letter). Psychosomatics 37 : 571 573.
9. Church J, Lodge D, Berry SC (1985) Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur J Pharmacol 111 : 185 190.
10. Church J, Shacklock JA, Baimnbridge KG (1991) Dextromethorphan and phencyclidine receptor ligands: Differential effects on potassium and NMDA-evoked increases in cystolic free calcium concentration. Neurosci Lett 124 : 232 234.
11. Cook J, Mclean S, Sahn E (1996) Bullous mastocytosis in an infant associated with the use of a nonprescription cough suppressant. Pediatr Dermatol 5 : 410 414.
12. Craviso GL, Musacchio JM (1983a) High-affinity dextromethorphan binding sites in guinea pig brain. I Initial characterization. Mol Pharmacol 23 : 619 628.
13. Craviso GL, Musacchio JM (1983b) High-affinity dextromethorphan binding sites in guinea pig brain. II Initial characterization. Mol Pharmacol 23 : 629 640.
14. Croucher MJ, Collins JF, Meldrum BS (1982) Anticonvulsant action of excitatory amino acid antagonists. Science 216 : 899 901.
15. Darboe MN, Keenan GR, Richards TK (1993) The abuse of DM-based cough syrup: A pilot study of the community of Waynesboro, Pennsylvania. Adolescence 31 : 633 644.
16. DeZeeuw RA, Johnkman JG (1988) Genetic differences in oxidative drug metabolism. In : Proceedings of the International Association of Forensic Toxicologists, Groningen, The Netherlands, 53 64.
17. Dickenson AH (1994) Neurophysiology of opioid poorly responsive pain. Cancer Surv 21 : 5 16.
18. Drachtman RA, Cole PD, Golden CB, Jill James S, Melnyk S, Aisner J, Kamen B (2002) Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 19 : 319 327.
19. Ducharme J, Abdullah S, Wainer IW (1996) Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. J Chromatogr B: Biomed Appl 678 : 113 128.
20. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo MJ (1988) Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 151 : 151 154.
21. Hagen N (1991) An approach to cough in cancer patients. J Pain Symptom Manage 6 : 257 262.
22. Hollander D, Pradas J, Kaplan R, McLeod HL, Evans WE, Munsat TL (1994) High-dose dextromethorphan in amyotrophic lateral sclerosis: Phase I safety and pharmacokinetic studies. Ann Neurol 36 : 920 924.
23. Katz N (2000) Morphidex double blind multiple-dose studies in chronic pain patients. J Pain Symptom Manage 19 : S37 S41.
24. Kawamata T, Omote K, Kawamata M, Namiki A (1998) Premedication with oral dextromethorphan reduces postoperative pain after tonsillectomy. Anesth Analg 86 : 594 597.
25. Kishi T, Tanaka Y, Ueda K (2000) Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer 89 : 925 931.
26. Knowles SR, Weber E (1998) Dextromethorphan anaphylaxis. J Allergy Clin Immunol 102 : 316 317.
27. Konrad D, Sobetzko D, Schmitt B (2000) Insulin-dependent diabetes mellitus induced by the antitussive agent dextromethorphan. Diabetologia 43 : 261 262.
28. Kupfer A, Schmid B, Pfaff G (1986) Pharmacogenetics of dextromethorphan O-demethylation in man. Xenobiotica 16 : 421 433.
29. Manaboriboon B, Chomchai C (2005) Dextromethorphan abuse in Thai adolescents: A report of two cases and review of literature. J Med Assoc Thailand 88 : S242 245.
30. Mansky P, Jasinski DR (1970) Effects of dextromethorphan (D) in man. Pharmacologist 12 : 231.
31. Mendell LM (1966) Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 16 : 316 332.
32. Mercandante S, Casuccio A, Genovese G (1998) Ineffectiveness of dextromethorphan in cancer pain. J Pain Symp Manag 16 : 317 322.
33. Miller SC (2005) Dextromethorphan psychosis, dependence and physical withdrawal. Addiction Biology 10 : 325 327.
34. Motassim N, Decolin D, Le Dinh T, Nicholas A, Siest G (1987) Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using precolumn switching system for sample clean-up. J Chromatogr 422 : 340 345.
35. Pender ES, Parks BR (1991) Toxicity with dextromethorphan-containing preparations: A literature review of two additional cases. Pediatr Emerg Care 7 : 163 165.
36. Price D, Mao J, Lu J, Caruso FS, Frenk H, Mayer D (1996) Effects of the combined oral administration of NSAIDS and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain 68 : 119 127.
37. Product Information: Pertussin Children's Strength(R) dextromethorphan hydrobromide (1999) Englewood, CO : Physicians' Desk Reference (electronic version), MICROMEDEX, Inc.
38. Quinn CT, Kamen BA (1996) A biochemical perspective of methotrexate neurotoxicity with insight 1 on non folate rescue modalities. J Invest Med 44 : 522 530.
39. Rivers N, Horner B (1970) Possible lethal reaction between Nardil and dextromethorphan. Can Med Assoc J 103 : 85.
40. Steinberg GK, Bell TE, Yenari MA (1996) Dose escalation safety and tolerance study of the N-methyl aspartate antagonist DM in neurosurgery patients. J Neurosurg 84 : 860 866.
41. Stubb S, Reitamo S (1990) Fixed-drug eruption due to dextromethorphan. Arch Dermatol 126 : 970 971.
42. Warden CR, Diekema DS, Robertson WO (1997) Dystonic reaction associated with dextromethorphan ingestion in a toddler. Pediatr Emerg Care 13 : 214 215.
43. Weinbroum AA, Rudick V, Paret G, Ben-Abraham R (2000) The role of dextromethorphan in pain control. Can J Anesth 47 : 585 596.
44. Weinbroum AA, Gorodetzky A, Nirkin A, Kollender Y, Bickels J, Marouani N, Rudick V, Meller I (2002) Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: A randomized, placebo-controlled, double-blind study. Cancer 95 : 1164 1170.
45. Weinbroum AA, Bender B, Bickels J, Nirkin A, Marouani N, Chazam S, Meller I, Kollender Y (2003) Preoperative and postoperative dextromethorphan provides sustained reduction in postoperative pain and patient-controlled epidural analgesia requirement: A randomized, placebo-controlled, double-blind study in lower-body bone malignancy-operated patients. Cancer 97 : 2334 2340.
46. Weinbroum AA, Bender B, Nirkin A, Chazan S, Meller I, Kollender Y (2004) Dextromethorphan-associated epidural patient-controlled analgesia provides better pain- and analgesics-sparing effects than dextromethorphan-associated intravenous patient-controlled analgesia after bone-malignancy resection: A randomized, placebo-controlled, double-blinded study. Anesth Analg 98 : 714 722.
47. Woodworth JR, Denis SRK, Moore L, Rotenberg KS (1987) The polymorphic metabolism of dextromethorphan. J Clin Pharmacol 27 : 139 143.
48. Woolf CJ, Chong MS (1993) Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 77 : 362 379.
49. Wong CS, Wu CS, Jyh-Cherng Y, Meei-Shyuan M, Pao-Luh T (1999) Preincisional dextromethorphan decreases postoperative pain and opioid requirement after modified radical mastectomy. Can J Anesth 46 : 1122 1126.